Menu
Not yet recruiting NCT07415161

Oxygen Reserve Index (ORi) in Identifying Desaturation

No phase Interventional Apneic Oxygenation Endolarengeal Surgery Oxygen Reserve Index

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: oxygen monitoring techniques.
Who it may be relevant to
Registry conditions: Apneic Oxygenation, Endolarengeal Surgery, Oxygen Reserve Index. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Role of Oxygen Reserve Index (ORi) in Identifying Early Desaturation During Endolaryngeal Surgery: A Randomized Clinical Trial

Overview

This randomized clinical trial investigates whether Oxygen Reserve Index (ORi) monitoring enables earlier detection of impending hypoxemia compared with conventional pulse oximetry during apneic intermittent ventilation in adult patients undergoing endolaryngeal surgery under general anesthesia. By providing continuous, noninvasive assessment of oxygen reserve in the hyperoxic range, ORi may offer an earlier warning of oxygen depletion before peripheral oxygen saturation declines. The study compares time to reventilation thresholds, arterial blood gas parameters, and perioperative respiratory outcomes between ORi-guided and standard SpO₂-guided monitoring strategies.

Detailed description

This prospective, single-center, randomized clinical trial was designed to evaluate the role of the Oxygen Reserve Index (ORi) in the early detection of hypoxemia during apneic intermittent ventilation in adult patients undergoing elective endolaryngeal surgery under general anesthesia. Endolaryngeal procedures require shared airway management and frequently involve apneic periods, during which conventional pulse oximetry may fail to provide timely warning of declining oxygen reserves due to the plateau phase of the oxyhemoglobin dissociation curve. Eligible patients aged 18 years and older with ASA physical status I-III were randomly assigned to either an ORi-monitored group or a control group monitored with standard peripheral oxygen saturation (SpO₂). All patients underwent standardized anesthesia induction, preoxygenation, and apneic intermittent ventilation. In the ORi group, the threshold for resuming ventilation was defined as ORi reaching zero, whereas in the control group ventilation was resumed when SpO₂ decreased to 90%. The primary outcome was the time from the onset of apnea to the predefined reventilation threshold. Secondary outcomes included arterial blood gas parameters (pH, PaO₂, PaCO₂) at the time of reventilation, end-tidal carbon dioxide levels, perioperative lung ultrasound findings, post-anesthesia care unit length of stay, and postoperative respiratory outcomes. This study aims to determine whether ORi monitoring provides earlier and clinically meaningful warning of oxygen reserve depletion compared with conventional pulse oximetry, potentially improving patient safety during shared-airway surgery.

Interventions

  • Procedure oxygen monitoring techniques
    to determine whether ORi monitoring provides earlier and clinically meaningful warning of oxygen reserve depletion compared with conventional pulse oximetry, potentially improving patient safety during shared-airway surgery.

Primary outcome measures

  • Time to Reventilation Threshold [Time frame: From the onset of apnea until the predefined reventilation threshold is reached during the intraoperative period (within minutes).]
Secondary outcome measures (4)
  • Arterial Blood Gas Parameters at Reventilation [Time frame: From the onset of apnea until the predefined reventilation threshold is reached during the intraoperative period (within minutes).]
  • Perioperative Lung Ultrasound Findings [Time frame: Preoperatively (before anesthesia induction) and postoperatively in the post-anesthesia care unit (within 1 hour after surgery).]
  • Postoperative Oxygenation [Time frame: postoperatively in the post-anesthesia care unit (within 1 hour after surgery).]
  • End-Tidal Carbon Dioxide (EtCO₂) Level [Time frame: During the apneic period, measured at the time of reventilation during surgery.]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • Scheduled for elective endolaryngeal surgery
  • Planned general anesthesia with apneic intermittent ventilation
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Ability to provide written informed consent

Exclusion criteria

  • Age under 18 years
  • Preoperative chronic hypoxemia (baseline SpO₂ < 95%)
  • Patients transferred from the intensive care unit
  • ASA physical status IV or higher
  • Refusal or inability to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Istanbul University, Department of anesthesiology — Istanbul

Publications

  • Fleming NW, Singh A, Lee L, Applegate RL 2nd. Oxygen Reserve Index: Utility as an Early Warning for Desaturation in High-Risk Surgical Patients. Anesth Analg. 2021 Mar 1;132(3):770-776. doi: 10.1213/ANE.0000000000005109. PMID 32815872
  • Szmuk P, Steiner JW, Olomu PN, Ploski RP, Sessler DI, Ezri T. Oxygen Reserve Index: A Novel Noninvasive Measure of Oxygen Reserve--A Pilot Study. Anesthesiology. 2016 Apr;124(4):779-84. doi: 10.1097/ALN.0000000000001009. PMID 26978143

Identifiers

NCT: NCT07415161 · 2024/1568

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗